Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 2
1982 pubmed

Stimulation of lymphocyte proliferation to monitor fractionation of thymus extracts.

Stepien. H H; Sakura. N N; Dahmen. J J; Lundanes. E E; Rampold. G G; Folkers. K K

Key Findings

  • Thymosin‑alpha‑1 was inactive in the lymphocyte proliferation assay
  • Crude calf thymus outer fraction showed activity
  • The assay used spleen cells from mice lacking a thymus, a specific immune model

Practical Outcomes

  • For biohackers, this study suggests that thymosin‑alpha‑1 may not directly increase lymphocyte proliferation, so expectations of a simple immune‑boosting effect should be tempered. It doesn’t provide dosing guidance or a new protocol, but highlights the need for more evidence before using thymosin‑alpha‑1 for immune enhancement.

Summary

The researchers tested various fractions of bovine thymus extracts on mouse spleen cells to see which ones boost cell growth. They found that a crude calf thymus outer fraction was active, but the synthetic peptide thymosin‑alpha‑1 (and some other fractions) did not stimulate lymphocyte proliferation in this test.

Abstract

Multi-step fractionations by solvent extractions, gel filtrations, ion-exchange chromatography, etc., of bovine thymus extracts were monitored by a standardized assay, in vitro, which led to the described peptides, thymones A, B and C. The assay uses spleen cells from neonatally thymectomized mice as tissue relevant to immunoregulation. Assay of incorporation of [3H]-thymidine into DNA located peaks of activities. Calf thymus outer fraction ("CTO") showed activity, but Fraction 5, synthetic thymosin alpha 1, [G1n1]-FTS, and glutathione, were inactive in this assay.

Study Information

Provider

pubmed

Year

1982